CBPO - China Biologic Products Holdings, Inc.

NasdaqGS - NasdaqGS Delayed Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/201612/31/201512/31/2014
Total Revenue341,169.426296,457.902243,251.658
Cost of Revenue124,034.448106,482.62680,025.375
Gross Profit217,134.978189,975.276163,226.283
Operating Expenses
Research Development7,021.9926,024.3684,161.901
Selling General and Administrative66,198.36451,364.96942,837.394
Non Recurring--5,068.075
Others---
Total Operating Expenses---
Operating Income or Loss143,914.622132,585.939111,158.913
Income from Continuing Operations
Total Other Income/Expenses Net7,739.8895,551.1056,644.886
Earnings Before Interest and Taxes154,173.712136,825.766126,449.98
Interest Expense254.4711,727.3353,697.819
Income Before Tax153,919.241135,098.431122,752.161
Income Tax Expense25,125.8220,992.91326,639.527
Minority Interest58,936.23484,618.67563,174.703
Net Income From Continuing Ops107,298.50887,731.42579,563.021
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income104,779.30789,042.70370,916.84
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares104,779.30789,042.70370,916.84